Chemistry:Sivelestat

From HandWiki
Short description: Chemical compound
Sivelestat
Sivelestat.svg
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
IV
ATC code
  • None
Legal status
Legal status
  • US: Not approved
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC20H22N2O7S
Molar mass434.46 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Sivelestat (INN, research name ONO 5046, marketed as Elaspol) is an inhibitor of human neutrophil elastase.[1]

It is used in the treatment of acute respiratory failure[2] and preliminary studies show it may also improve neuropathic pain.[3]

Synthesis

Sivelestat is synthesised as follows:[4]

Sivelestat scheme.png

References

  1. "ONO-5046, a novel inhibitor of human neutrophil elastase". Biochemical and Biophysical Research Communications 177 (2): 814–820. June 1991. doi:10.1016/0006-291X(91)91862-7. PMID 2049103. 
  2. "[Acute respiratory failure due to pneumocystis pneumonia successfully treated with combined use of sivelestat sodium hydrate]" (in Japanese). Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society 46 (6): 461–465. June 2008. PMID 18592991. 
  3. "Repurposing a leukocyte elastase inhibitor for neuropathic pain". Nature Medicine 21 (5): 429–430. May 2015. doi:10.1038/nm.3861. PMID 25951529. 
  4. Imaki K, Arai Y, Okegawa T, "Derivatives of p-substituted phenyl ester of pivalic acid", US patent 5017610, issued 21 May 1991, assigned to Ono Pharmaceutical Co Ltd